Entia Biosciences Launches Medical Food for Treatment of Rheumatoid Arthritis
5/2/2012 7:14:21 AM
SHERWOOD, Ore., May 2, 2012 (GLOBE NEWSWIRE) -- Entia Biosciences, Inc. (OTCBB:ERGO) (ENTIA) has developed a new medical food for the treatment of Rheumatoid Arthritis (RA), a systemic autoimmune disease that causes pain, stiffness, swelling, and loss of function in the joints. RA affects roughly 1-2% of the world-wide population and occurs when a person's immune system mistakenly starts attacking healthy tissue, causing inflammation in the joints and a progressive loss of flexibility. If not managed properly, over time, RA can cause joint damage and can even result in permanent joint destruction.